HAR1A lentivirus

HAR1A lentivirus is an experimental gene therapy construct designed to overexpress the long non-coding RNA (lncRNA) Highly Accelerated Region 1A (HAR1A). In the context of oncology research, particularly in lung adenocarcinoma (LUAD), HAR1A has been identified as a tumor suppressor that is frequently downregulated and negatively associated with patient prognosis. The lentiviral delivery of HAR1A aims to restore its expression, which in turn inhibits cell proliferation and induces apoptosis in non-small cell lung cancer (NSCLC) cells. Mechanistically, HAR1A exerts its tumor-suppressive effects by regulating the STAT3 signaling pathway. Preclinical studies in mouse models have verified that restoring HAR1A levels via lentiviral transduction can significantly suppress tumor growth, highlighting its potential as a therapeutic target or agent in gene therapy for lung cancer.

Other names

Highly Accelerated Region 1A lentivirusLentiviral-HAR1ALentiviral-HAR-1ALentiviral-HAR 1A